Homocysteine induces caspase activation by endoplasmic reticulum stress in platelets from type 2 diabetics and healthy donors

Summary

Diabetes mellitus is a disease characterised by hyperglycaemia and associated with several cardiovascular disorders, including angiopathy and platelet hyperactivity, which are major causes of morbidity and mortality in type 2 diabetes mellitus. In type 2 diabetic patients, homo-cysteine levels are significantly increased compared with healthy subjects. Hyperhomocysteinaemia is an independent risk factor for macro-and microangiopathy and mortality. The present study is aimed to investigate the effect of homocysteine on platelet apoptosis. Changes in cytosolic or intraluminal free Ca²⁺ concentration were determined by fluorimetry. Caspase activity and phosphorylation of the eukaryotic initiation factor 2α (eIF2α) were explored by Western blot. Our results indicate that homocysteine releases Ca²⁺ from agonist sensitive stores, enhances eIF2α phosphorylation at Ser⁵¹ and activates caspase-3 and -9 independently of extracellular Ca²⁺. Homocysteine induced activation of caspase-3 and -9 was abolished by salubrinal, an agent that prevents endoplasmic reticulum (ER) stress-induced apoptosis. Homo-cysteine-induced platelet effects were significantly greater in type 2 diabetics than in healthy subjects. These findings demonstrate that homocysteine induces ER stress-mediated apoptosis in human platelets, an event that is enhanced in type 2 diabetic patients, which might be involved in the pathogenesis of cardiovascular complications associated with type 2 diabetes mellitus.

Keywords

Homocysteine - ER stress - caspases - apoptosis - diabetes mellitus

• References

• 1 Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999; 19: 217-246.
• 2 Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost 2005; 94: 907-915.
• 3 Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res 2007; 04: 143-150.
• 4 Signorello MG, Viviani GL, Armani U. et al. Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 2007; 120: 607-613.
• 5 Leoncini G, Signorello MG, Piana A. et al. Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients. Thromb Res 1997; 86: 153-160.
• 6 Vinik AI, Erbas T, Park TS. et al. Platelet dysfunction in type 2 diabetes. Diabetes Care 2001; 24: 1476-1485.
• 7 El Haouari M, Rosado JA. Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review. Blood Cells Mol Dis 2008; 41: 119-123.
• 8 Jardin I, Redondo PC, Salido GM. et al. Endogenously generated reactive oxygen species reduce PMCA activity in platelets from patients with non-insulin-dependent diabetes mellitus. Platelets 2006; 17: 283-288.
• 9 Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 1999; 81: 165-176.
• 10 Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 2005; 03: 1646-1654.
• 11 Gellekink H, Muntjewerff JW, Vermeulen SH. et al. Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk. Thromb Haemost 2007; 98: 1226-1231.
• 12 Vaya A, Gomez I, Mira Y. et al. Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects. Thromb Haemost 2008; 99: 1132-1134.
• 13 Lijfering WM, Coppens M, van de Poel MH. et al. The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects. Thromb Haemost 2007; 98: 457-463.
• 14 Bae ON, Lim KM, Noh JY. et al. Trivalent methylated arsenical-induced phosphatidylserine exposure and apoptosis in platelets may lead to increased thrombus formation. Toxicol Appl Pharmacol 2009; 239: 144-153.
• 15 Leytin V, Allen DJ, Lyubimov E. et al. Higher thrombin concentrations are required to induce platelet apoptosis than to induce platelet activation. Br J Haematol 2007; 136: 762-764.
• 16 Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. Thrombin-triggered platelet apoptosis. J Thromb Haemost 2006; 04: 2656-2663.
• 17 Lopez JJ, Salido GM, Gomez-Arteta E. et al. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost 2007; 05: 1283-1291.
• 18 Lopez JJ, Salido GM, Pariente JA. et al. Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets. J Thromb Haemost 2008; 06: 1780-1788.
• 19 Lopez JJ, Redondo PC, Salido GM. et al. N,N,N‘,N‘-tetrakis(2-pyridylmethyl)ethylenediamine induces apoptosis through the activation of caspases-3 and –8 in human platelets. A role for endoplasmic reticulum stress. J Thromb Haemost 2009; 07: 992-999.
• 20 Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 2004; 11: 372-380.
• 21 Groenendyk J, Michalak M. Endoplasmic reticulum quality control and apoptosis. Acta Biochim Pol 2005; 52: 381-395.
• 22 Jimbo A, Fujita E, Kouroku Y. et al. ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. Exp Cell Res 2003; 283: 156-166.
• 23 Cheung HH, Kelly NL, Liston P. et al. Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. Exp Cell Res 2006; 312: 2347-2357.
• 24 Endo M, Mori M, Akira S. et al. C/EBP homologous protein (CHOP) is crucial for the induction of caspase-11 and the pathogenesis of lipopolysaccharide-induced inflammation. J Immunol 2006; 176: 6245-6253.
• 25 Shiraishi H, Okamoto H, Yoshimura A. et al. ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1. J Cell Sci 2006; 119: 3958-3966.
• 26 Alexandru N, Jardin I, Popov D. et al. Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus. J Cell Mol Med 2008; 12: 2015-2026.
• 27 Rosado JA, Lopez JJ, Gomez-Arteta E, Redondo PC, Salido GM, Pariente JA. Early caspase-3 activation independent of apoptosis is required for cellular function. J Cell Physiol 2006; 209: 142-152.
• 28 Bouaziz A, Amor NB, Woodard GE. et al. Tyrosine phosphorylation / dephosphorylation balance is involved in thrombin-evoked microtubular reorganisation in human platelets. Thromb Haemost 2007; 98: 375-384.
• 29 Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca²⁺ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450.
• 30 Lopez JJ, Redondo PC, Salido GM. et al. Two distinct Ca²⁺ compartments show differential sensitivity to thrombin, ADP and vasopressin in human platelets. Cell Signal 2006; 18: 373-381.
• 31 Lopez JJ, Camello-Almaraz C, Pariente JA. et al. Ca²⁺ accumulation into acidic organelles mediated by Ca²⁺- and vacuolar H⁺-ATPases in human platelets. Biochem J 2005; 390: 243-252.
• 32 Li Y, Woo V, Bose R. Platelet hyperactivity and abnormal Ca²⁺ homeostasis in diabetes mellitus. Am J Physiol Heart Circ Physiol 2001; 280: H1480-1489.
• 33 Saavedra FR, Redondo PC, Hernandez-Cruz JM. et al. Store-operated Ca²⁺ entry and tyrosine kinase pp60^src hyperactivity are modulated by hyperglycemia in platelets from patients with non insulin-dependent diabetes mellitus. Arch Biochem Biophys 2004; 432: 261-268.
• 34 Lee YY, Cevallos RC, Jan E. An upstream open reading frame regulates translation of GADD34 during cellular stresses that induce eIF2alpha phosphorylation. J Biol Chem 2009; 284: 6661-6673.
• 35 Lewerenz J, Maher P. Basal levels of eIF2{alpha} phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J Biol Chem 2009; 284: 1106-1115.
• 36 Nicholson DW, Ali A, Thornberry NA. et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
• 37 Ben Amor N, Pariente JA, Salido GM. et al. Caspases 3 and 9 are translocated to the cytoskeleton and activated by thrombin in human platelets. Evidence for the involvement of PKC and the actin filament polymerization. Cell Signal 2006; 18: 1252-1261.
• 38 Zou H, Li Y, Liu X. et al. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999; 274: 11549-11556.
• 39 Boyce M, Bryant KF, Jousse C. et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005; 307: 935-939.
• 40 Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001; 15: 44-54.
• 41 Rosado JA, Saavedra FR, Redondo PC, Hernandez-Cruz JM, Salido GM, Pariente JA. Reduced plasma membrane Ca²⁺-ATPase function in platelets from patients with non-insulin-dependent diabetes mellitus. Haematologica 2004; 89: 1142-1144.
• 42 Sobol AB, Watala C. The role of platelets in diabetes-related vascular complications. Diabetes Res Clin Pract 2000; 50: 1-16.
• 43 Avogaro A, de Kreutzenberg SV, Fadini GP. Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid?. Free Radic Biol Med 2008; 44: 1209-1215.
• 44 Alexandru N, Constantin A, Popov D. Carbonylation of platelet proteins occurs as consequence of oxidative stress and thrombin activation, and is stimulated by ageing and type 2 diabetes. Clin Chem Lab Med 2008; 46: 528-536.
• 45 Leoncini G, Bruzzese D, Signorello MG. Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets. J Thromb Haemost 2006; 04: 209-216.
• 46 Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyper-homocyst(e)inemia in humans. Circulation 1999; 100: 1161-1168.
• 47 Pariente JA, Camello C, Camello PJ, Salido GM. Release of calcium from mitochondrial and nonmitochondrial intracellular stores in mouse pancreatic acinar cells by hydrogen peroxide. J Membr Biol 2001; 179: 27-35.
• 48 Qin S, Inazu T, Yamamura H. Activation and tyrosine phosphorylation of p72^syk as well as calcium mobilization after hydrogen peroxide stimulation in peripheral blood lymphocytes. Biochem J 1995; 308: 347-352.
• 49 Redondo PC, Salido GM, Rosado JA. et al. Effect of hydrogen peroxide on Ca²⁺ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms. Biochem Pharmacol 2004; 67: 491-502.
• 50 Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001; 15: 2922-2933.
• 51 Wang J, Weiss I, Svoboda K, Kwaan HC. Thrombogenic role of cells undergoing apoptosis. Br J Haematol 2001; 115: 382-391.
• 52 Balasubramanian V, Grabowski E, Bini A. et al. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 2002; 100: 2787-2792.
• 53 Liu CY, Kaufman RJ. The unfolded protein response. J Cell Sci 2003; 116: 1861-1862.
• 54 Zhang C, Cai Y, Adachi MT. et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 2001; 276: 35867-35874.
• 55 Kapoor A, Sanyal AJ. Endoplasmic reticulum stress and the unfolded protein response. Clin Liver Dis 2009; 13: 581-590.
• 56 Kitamura M. Endoplasmic reticulum stress and unfolded protein response in renal pathophysiology: Janus faces. Am J Physiol Renal Physiol 2008; 295: F323-334.
• 57 Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008; 29: 42-61.
• 58 Sundar Rajan S, Srinivasan V, Balasubramanyam M, Tatu U. Endoplasmic reticulum (ER) stress & diabetes. Indian J Med Res 2007; 125: 411-424.